New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough and phlegm granules, cold and flu granules, Wuhu San, Wei Funing capsules, and other proprietary Chinese medicine products. In addition, it engages in cultivation of Chinese herbal medicine; investment management; retail business; wholesale trading activities; and provision of resident services. The company was formerly known as Hengkang Medical Group Co.,Ltd. New Journey Health Technology Group Co.,LTD was founded in 2001 and is headquartered in Beijing, China.
Research context
Hengkang Medical Group Co.,Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Hengkang Medical Group Co.,Ltd is currently in a long term uptrend where the price is trading 47.1% above its 200 day moving average.
From a valuation standpoint, the stock is 81.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Hengkang Medical Group Co.,Ltd's total revenue sank by 15.2% to $751M since the same quarter in the previous year.
Its net income has increased by 98.8% to $-1M since the same quarter in the previous year.
Finally, its free cash flow fell by 115.4% to $-31M since the same quarter in the previous year.
Based on the above factors, Hengkang Medical Group Co.,Ltd gets an overall score of 3/5.